WINT

0.00020.00%
MS

Mark Strobeck

President, CEO & Director

Dr. Mark Strobeck, Ph.D., serves as Independent Director at Windtree Therapeutics, Inc. since June 2023 and served as its Lead Independent Director since August 13, 2024 until December 2024. He is Independent Chairman of the Board of Windtree Therapeutics, Inc. since January 2025. He has served as the President, Chief Executive Officer and Director Rockwell Medical, Inc. since July 1, 2022. Dr. Strobeck joined Aquilo Partners, L.P. in 2021. He was Managing Director at Aquilo Partners, L.P. from May 2021 to June 2022. He served as Executive Vice President and Chief Operating Officer of Assertio Holdings, Inc. from May 2020 to December 2020. He had many years of operating, business development, capital raising and investing experience in life sciences for both private and public biotechnology companies. Dr. Strobeck was Executive Vice President and Chief Operating Officer of Zyla Life Sciences from September 2015 through its merger with Assertio Holdings, Inc. in May 2020 and previously served as Zyla’s Chief Business Officer from January 2014 to September 2015. Before his employment at Zyla, he served as Zyla’s advisor from June 2012 to December 2013. From January 2012 to December 2013, he served as President and Chief Executive Officer and a director of Corridor Pharmaceuticals, Inc., a pharmaceuticals company, which was acquired by AstraZeneca plc in 2014. From December 2010 to October 2011, Dr. Strobeck served as Chief Business Officer of Topaz Pharmaceuticals Inc., a specialty pharmaceutical company acquired by Sanofi Pasteur in the fourth quarter of 2011. From June 2010 to November 2010 and October 2011 to January 2012, Dr. Strobeck worked as a Consultant. From January 2008 to May 2010, Dr. Strobeck served as Chief Business Officer of Trevena, Inc., a pharmaceutical company. Prior to joining Trevena, Dr. Strobeck held management roles at GlaxoSmithKline plc, a pharmaceuticals company and venture capital firms SR One Limited and EuclidSR Partners, L.P. Dr. Strobeck served on the board of directors of Horse Power For Life, a nonprofit organization dedicated to improving the quality of life for individuals diagnosed with cancer, from 2012 to 2024. Dr. Strobeck received his B.S. in Biology from St. Lawrence University in 1993 and his Ph.D. in Pharmacology and Biophysics from the University of Cincinnati in 1999 and completed his post-doctoral fellowship in Cardiovascular Gene Regulation at the University of Pennsylvania in 2001.

Positions